Your browser doesn't support javascript.
loading
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intolerance.
Nicholls, StephenJ; Lincoff, A Michael; Bays, Harold E; Cho, Leslie; Grobbee, Diederick E; Kastelein, John Jp; Libby, Peter; Moriarty, Patrick M; Plutzky, Jorge; Ray, Kausik K; Thompson, Paul D; Sasiela, William; Mason, Denise; McCluskey, Jaclyn; Davey, Deborah; Wolski, Kathy; Nissen, Steven E.
Affiliation
  • Nicholls S; Monash Cardiovascular Research Centre, Monash University, Melbourne, Australia. Electronic address: stephen.nicholls@monash.edu.
  • Lincoff AM; Department of Cardiovascular Medicine, Cleveland Clinic and Cleveland Clinic Coordinating Center for Clinical Research.
  • Bays HE; Louisville Metabolic and Atherosclerosis Research Center, Louisville, KY.
  • Cho L; Department of Cardiovascular Medicine, Cleveland Clinic and Cleveland Clinic Coordinating Center for Clinical Research.
  • Grobbee DE; University Medical Center Utrecht, Julius Center, Utrecht, Netherlands.
  • Kastelein JJ; Department of Vascular Medicine, University of Amsterdam Academic Medical Center, Amsterdam, Netherlands.
  • Libby P; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA.
  • Moriarty PM; Clinical Pharmacology, University of Kansas Medical Center, Kansas City, Kansas.
  • Plutzky J; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA.
  • Ray KK; Department of Primary Care & Public Health, Imperial College London, London, England.
  • Thompson PD; Division of Cardiology, Hartford Hospital, Hartford, CT.
  • Sasiela W; Esperion Therapeutics, Ann Arbor, MI.
  • Mason D; Department of Cardiovascular Medicine, Cleveland Clinic and Cleveland Clinic Coordinating Center for Clinical Research.
  • McCluskey J; Department of Cardiovascular Medicine, Cleveland Clinic and Cleveland Clinic Coordinating Center for Clinical Research.
  • Davey D; Department of Cardiovascular Medicine, Cleveland Clinic and Cleveland Clinic Coordinating Center for Clinical Research.
  • Wolski K; Department of Cardiovascular Medicine, Cleveland Clinic and Cleveland Clinic Coordinating Center for Clinical Research.
  • Nissen SE; Department of Cardiovascular Medicine, Cleveland Clinic and Cleveland Clinic Coordinating Center for Clinical Research.
Am Heart J ; 235: 104-112, 2021 05.
Article in En | MEDLINE | ID: mdl-33470195
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Dicarboxylic Acids / Drug Tolerance / Fatty Acids Type of study: Clinical_trials / Guideline / Incidence_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Journal: Am Heart J Year: 2021 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Dicarboxylic Acids / Drug Tolerance / Fatty Acids Type of study: Clinical_trials / Guideline / Incidence_studies / Prognostic_studies Limits: Aged / Female / Humans / Male Language: En Journal: Am Heart J Year: 2021 Document type: Article Country of publication: